“…(Geary et al, 2017, Ishaq and Jafri, 2017). Because most of the price is more expensive, the way of administration is limited, adverse reactions and side effects and other factors are not suitable for long-term use, so it is urgent to develop high efficiency and low toxicity drugs for cerebral ischemia diseases (Faux et al, 2017). In recent years, scholars have turned their attention to the development of traditional Chinese medicine or Chinese medicine preparation at home and abroad.…”